Clinical Research on Xuebijing Injection in Prevention of Radiation-induced Lung Injury
|更新时间:2024-01-04
|
Clinical Research on Xuebijing Injection in Prevention of Radiation-induced Lung Injury
Chinese Journal of Experimental Traditional Medical FormulaeVol. 18, Issue 24, Pages: 320-323(2012)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2012
稿件说明:
移动端阅览
YANG Cheng-liang, QIU Rong-liang, YE Ke, et al. Clinical Research on Xuebijing Injection in Prevention of Radiation-induced Lung Injury[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(24): 320-323.
DOI:
YANG Cheng-liang, QIU Rong-liang, YE Ke, et al. Clinical Research on Xuebijing Injection in Prevention of Radiation-induced Lung Injury[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(24): 320-323.DOI:
Clinical Research on Xuebijing Injection in Prevention of Radiation-induced Lung Injury
Objective:To explore the prevention effect of Xuebijing injection on radiation-induced lung injury in patients with non-small cell lung cancer (NSCLC). Method: Eighty three cases of NSCLC patients underwent radiotherapy and confirmed by pathological examinations were randomly divided into two groups. The treatment group (n=42) received Xuebijing injection from the first day of radiotherapy
the control group (n=41) received radiotherapy alone. The levels of tumor necrosis factor-α (TNF-α)
coagulation function
KPS scoring
and incidence of radiation-induced lung injury within 6-month-follow up were observed. Result: The levels of TNF-α in the two groups at the second week and the end of radiotherapy increased obviously
while the increasing degree in the treatment group was obviously smaller than that in the control group. The coagulation function in the two groups had different degree of deterioration
while the deterioration degree in the treatment group was smaller than that in the control group. The KPS scoring in the treatment group at the second week and the end of radiotherapy decreased slightly
and obviously increased 6 months after radiotherapy
and was also higher than that in the control group at the end of radiotherapy and 6 months after the end of radiotherapy. The incidences of early and advanced radiation-induced lung injury in the treatment group were obviously lower than that in the control group. Conclusion: Xuebijing injection has the effect on anti-endotoxin
reducing inflammation factors releasing
adjusting anticoagulation and coagulation function
and increasing the KPS scoring
so as to effectively prevent radiation-induced lung injury and improve the life quality of the patients.